834 related articles for article (PubMed ID: 27730528)
21. Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.
Jakesz R; Jonat W; Gnant M; Mittlboeck M; Greil R; Tausch C; Hilfrich J; Kwasny W; Menzel C; Samonigg H; Seifert M; Gademann G; Kaufmann M; Wolfgang J;
Lancet; 2005 Aug 6-12; 366(9484):455-62. PubMed ID: 16084253
[TBL] [Abstract][Full Text] [Related]
22. Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life.
Gupta P; Sturdee DW; Palin SL; Majumder K; Fear R; Marshall T; Paterson I
Climacteric; 2006 Feb; 9(1):49-58. PubMed ID: 16428125
[TBL] [Abstract][Full Text] [Related]
23. An International Menopause Society study of climate, altitude, temperature (IMS-CAT) and vasomotor symptoms in urban Indian regions.
Stefanopoulou E; Shah D; Shah R; Gupta P; Sturdee DW; Hunter MS
Climacteric; 2014 Aug; 17(4):417-24. PubMed ID: 24099134
[TBL] [Abstract][Full Text] [Related]
24. Sleep in midlife women: effects of menopause, vasomotor symptoms, and depressive symptoms.
Lampio L; Polo-Kantola P; Polo O; Kauko T; Aittokallio J; Saaresranta T
Menopause; 2014 Nov; 21(11):1217-24. PubMed ID: 24755900
[TBL] [Abstract][Full Text] [Related]
25. Association of Vasomotor and Other Menopausal Symptoms with Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis.
Muka T; Oliver-Williams C; Colpani V; Kunutsor S; Chowdhury S; Chowdhury R; Kavousi M; Franco OH
PLoS One; 2016; 11(6):e0157417. PubMed ID: 27315068
[TBL] [Abstract][Full Text] [Related]
26. A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer.
McCaig FM; Renshaw L; Williams L; Young O; Murray J; Macaskill EJ; McHugh M; Hannon R; Dixon JM
Breast Cancer Res Treat; 2010 Feb; 119(3):643-51. PubMed ID: 19941160
[TBL] [Abstract][Full Text] [Related]
27. IMS study of climate, altitude, temperature and vasomotor symptoms in the United Arab Emirates.
Stefanopoulou E; Gupta P; Mostafa RM; Nosair N; Mirghani Z; Moustafa K; Al Kusayer G; Sturdee DW; Hunter MS
Climacteric; 2014 Aug; 17(4):425-32. PubMed ID: 24625187
[TBL] [Abstract][Full Text] [Related]
28. Menopausal symptoms among breast cancer patients: a potential indicator of favorable prognosis.
Chen Y; Dorjgochoo T; Bao PP; Zheng Y; Cai H; Lu W; Shu XO
PLoS One; 2013; 8(9):e75926. PubMed ID: 24098745
[TBL] [Abstract][Full Text] [Related]
29. Effect of omega-3 supplements on vasomotor symptoms in menopausal women: A systematic review and meta-analysis.
Mohammady M; Janani L; Jahanfar S; Mousavi MS
Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():295-302. PubMed ID: 30056356
[TBL] [Abstract][Full Text] [Related]
30. Vasomotor and sexual symptoms in older Australian women: a cross-sectional study.
Zeleke BM; Bell RJ; Billah B; Davis SR
Fertil Steril; 2016 Jan; 105(1):149-55.e1. PubMed ID: 26450529
[TBL] [Abstract][Full Text] [Related]
31. Correlation of Serum Estradiol and Duration of Anastrazole Therapy with Treatment Related Adverse Effects Among Postmenopausal Breast Cancer Women: A Cross-sectional Study.
Abubakar MB; Gan SH
Niger J Physiol Sci; 2017 Dec; 32(2):219-225. PubMed ID: 29485645
[TBL] [Abstract][Full Text] [Related]
32. Raloxifene effects on vasomotor and other climacteric symptoms in postmenopausal women.
Glusman JE; Huster WJ; Paul S
Prim Care Update Ob Gyns; 1998 Jul; 5(4):166. PubMed ID: 10838311
[TBL] [Abstract][Full Text] [Related]
33. Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States.
Williams RE; Kalilani L; DiBenedetti DB; Zhou X; Granger AL; Fehnel SE; Levine KB; Jordan J; Clark RV
Climacteric; 2008 Feb; 11(1):32-43. PubMed ID: 18202963
[TBL] [Abstract][Full Text] [Related]
34. Comparative efficacy study of 5-year letrozole or anastrozole in postmenopausal hormone receptor-positive early breast cancer.
Sendur MA; Aksoy S; Zengin N; Altundag K
J BUON; 2013; 18(4):838-44. PubMed ID: 24344006
[TBL] [Abstract][Full Text] [Related]
35. Sexual function after breast cancer.
Panjari M; Bell RJ; Davis SR
J Sex Med; 2011 Jan; 8(1):294-302. PubMed ID: 21199377
[TBL] [Abstract][Full Text] [Related]
36. Joint symptoms: a practical problem of anastrozole.
Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O; Sakamoto N
Breast Cancer; 2006; 13(3):284-288. PubMed ID: 16929123
[TBL] [Abstract][Full Text] [Related]
37. Incidence of joint symptoms and bone fractures in Japanese postmenopausal breast cancer patients treated with adjuvant anastrozole.
Okishiro M; Taguchi T; Kim SJ; Tanji Y; Shimazu K; Tamaki Y; Noguchi S
J Cancer Res Clin Oncol; 2009 Jun; 135(6):823-7. PubMed ID: 19034512
[TBL] [Abstract][Full Text] [Related]
38. Acupuncture for the treatment of hot flashes in patients with breast cancer receiving antiestrogen therapy: a pilot study in Korean women.
Jeong YJ; Park YS; Kwon HJ; Shin IH; Bong JG; Park SH
J Altern Complement Med; 2013 Aug; 19(8):690-6. PubMed ID: 23383974
[TBL] [Abstract][Full Text] [Related]
39. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
[TBL] [Abstract][Full Text] [Related]
40. Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Margolese RG; Cecchini RS; Julian TB; Ganz PA; Costantino JP; Vallow LA; Albain KS; Whitworth PW; Cianfrocca ME; Brufsky AM; Gross HM; Soori GS; Hopkins JO; Fehrenbacher L; Sturtz K; Wozniak TF; Seay TE; Mamounas EP; Wolmark N
Lancet; 2016 Feb; 387(10021):849-56. PubMed ID: 26686957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
